Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin in Prader-Willi Newborns
NCT01548521Phase 2Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Jul 2011
- Primary completion
- Feb 2012
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in Prader-Willi syndrome (PWS), sponsored by Centre hospitalier universitaire de Toulouse. Started Jul 2011; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NCT01548521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01548521.